Skip to main content

Table 2 Baseline characteristics of the participants1

From: Supplementation of arachidonic acid-enriched oil increases arachidonic acid contents in plasma phospholipids, but does not increase their metabolites and clinical parameters in Japanese healthy elderly individuals: a randomized controlled study

   

Group

 

Characteristics2

 

Placebo

Low-ARA

High-ARA

  

(n = 20)

(n = 22)

(n = 22)

Gender (Female)

n

12

13

12

Age

y

63.1 ± 3.8

62.8 ± 4.3

62.9 ± 4.2

BMI

kg/m2

21.5 ± 2.4

22.5 ± 2.0

22.5 ± 3.1

Alcohol consumption

    

   Positive

n

11

13

9

   Negative

n

9

9

13

Smoking status

    

   Positive

n

4

3

3

   Negative

n

16

19

19

Exercise

    

   Habitual

n

11

15

14

   Nonhabitual

n

9

7

8

hs-CRP

μg/dL

113 ± 98

106 ± 153

104 ± 116

PT

%

91.4 ± 8.5

91.4 ± 8.6

91.5 ± 6.5

HbA1c

%

4.9 ± 0.2

4.9 ± 0.3

4.9 ± 0.4

FA composition

    

   18:2n-6

%

18.33 ± 2.64

18.91 ± 2.16

17.78 ± 2.62

   20:4n-6

%

8.27 ± 1.26

8.61 ± 0.92

8.77 ± 1.32

   20:5n-3

%

2.85 ± 1.30

3.17 ± 1.42

3.59 ± 2.16

   22:6n-3

%

7.83 ± 1.42

8.10 ± 1.27

8.41 ± 2.29

  1. 1Values are means ± SD. No significance among the groups (ANOVA and Tukey-Kramer or Kruskal-Wallis tests).
  2. 2hs-CRP, high-sensitivity CRP; PT, prothrombin time; HbA1c, hemoglobin A1c; FA, fatty acid; 18:2n-6, linoleic acid; 20:4n-6, arachidonic acid; 20:5n-3, eicosapentaenoic acid; 22:6n-3, docosahexaenoic acid.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X